US Stock MarketDetailed Quotes

TXMD TherapeuticsMD

Watchlist

1.640
-0.010-0.61%

Close Sep 27 16:00 ET

1.640
0.0000.00%

Post 18:29 ET

18.91MMarket Cap-3037P/E (TTM)

TherapeuticsMD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-46.45%234K

-24.76%313K

-98.14%1.3M

-99.27%502K

-114.97%-53K

25.57%437K

-40.14%416K

2,619.12%69.96M

204.36%68.57M

-98.61%354K

Operating revenue

-46.45%234K

-24.76%313K

-98.14%1.3M

-99.27%502K

-114.97%-53K

25.57%437K

-40.14%416K

2,619.12%69.96M

204.36%68.57M

-98.61%354K

Cost of revenue

-0.36%1.4M

-93.30%354K

Gross profit

-46.45%234K

-98.10%1.3M

-99.27%502K

-53K

437K

5,755.34%68.57M

229.37%68.57M

Operating expense

-51.43%1.41M

-52.81%1.46M

-83.03%9.83M

-80.16%2.11M

-88.15%1.72M

-80.42%2.91M

-82.75%3.08M

-28.29%57.9M

113.69%10.65M

-75.82%14.52M

Selling and administrative expenses

-55.66%1.23M

-56.74%1.32M

-84.30%8.9M

-85.73%1.48M

-88.84%1.59M

-80.92%2.78M

-82.58%3.06M

-29.77%56.71M

114.34%10.34M

-75.62%14.25M

Depreciation amortization depletion

40.63%180K

392.59%133K

-22.72%922K

106.15%637K

-52.38%130K

-54.61%128K

-91.79%27K

--1.19M

--309K

--273K

-Depreciation and amortization

40.63%180K

392.59%133K

-22.72%922K

106.15%637K

-52.38%130K

-54.61%128K

-91.79%27K

--1.19M

--309K

--273K

Operating profit

52.31%-1.18M

57.18%-1.14M

-179.93%-8.52M

-102.78%-1.61M

87.79%-1.77M

83.36%-2.47M

85.08%-2.67M

113.40%10.66M

133.51%57.91M

63.63%-14.52M

Net non-operating interest income expense

88.89%-5K

-20K

-45K

-50K

Non-operating interest expense

-88.89%5K

--0

----

--20K

--45K

--50K

----

--0

Other net income (expense)

30.10%134K

-18.18%333K

108.14%781K

99.07%-88K

420.54%359K

743.75%103K

407K

-3,625.37%-9.59M

-118,362.50%-9.46M

-689.47%-112K

Special income (charges)

---1.26M

----

--0

----

--0

----

---9.47M

----

-Less：Restructuring and merger&acquisition

----

--0

----

--9.47M

----

-Less:Impairment of capital assets

--1.26M

----

--0

----

Other non- operating income (expenses)

1,254.37%1.4M

-18.18%333K

767.52%781K

-900.00%-88K

420.54%359K

743.75%103K

--407K

-143.01%-117K

37.50%11K

-689.47%-112K

Income before tax

56.50%-1.05M

64.98%-809K

-820.86%-7.74M

-103.27%-1.58M

90.20%-1.43M

83.77%-2.41M

87.08%-2.31M

101.35%1.07M

-3.38%48.45M

69.15%-14.63M

Income tax

-43K

Net income

54.85%-1.09M

79.63%-734K

-109.18%-10.28M

-101.14%-883K

88.34%-3.38M

-102.15%-2.41M

92.65%-3.6M

164.96%112M

280.87%77.7M

38.92%-28.97M

Net income continuous Operations

56.50%-1.05M

64.98%-809K

-816.85%-7.7M

-103.18%-1.54M

90.20%-1.43M

83.77%-2.41M

87.08%-2.31M

101.35%1.07M

-3.38%48.45M

69.15%-14.63M

Net income discontinuous operations

---40K

105.80%75K

-102.33%-2.58M

-97.75%658K

86.44%-1.94M

--0

95.85%-1.29M

219.13%110.92M

--29.25M

---14.33M

Minority interest income

Net income attributable to the parent company

54.85%-1.09M

79.63%-734K

-109.18%-10.28M

-101.14%-883K

88.34%-3.38M

-102.15%-2.41M

92.65%-3.6M

164.96%112M

280.87%77.7M

38.92%-28.97M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

54.85%-1.09M

79.63%-734K

-109.18%-10.28M

-101.14%-883K

88.34%-3.38M

-102.15%-2.41M

92.65%-3.6M

164.96%112M

280.87%77.7M

38.92%-28.97M

Basic earnings per share

62.50%-0.09

83.78%-0.06

-107.90%-0.98

-100.70%-0.06

89.78%-0.32

-101.87%-0.24

93.51%-0.37

157.29%12.41

271.00%8.55

44.31%-3.13

Diluted earnings per share

62.50%-0.09

83.78%-0.06

-108.19%-0.98

-100.74%-0.06

89.78%-0.32

-101.87%-0.24

93.51%-0.37

155.22%11.96

262.00%8.1

44.31%-3.13

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	-46.45%234K	-24.76%313K	-98.14%1.3M	-99.27%502K	-114.97%-53K	25.57%437K	-40.14%416K	2,619.12%69.96M	204.36%68.57M	-98.61%354K
Operating revenue	-46.45%234K	-24.76%313K	-98.14%1.3M	-99.27%502K	-114.97%-53K	25.57%437K	-40.14%416K	2,619.12%69.96M	204.36%68.57M	-98.61%354K
Cost of revenue			0	0	0			-0.36%1.4M	0	-93.30%354K
Gross profit	-46.45%234K		-98.10%1.3M	-99.27%502K	-53K	437K		5,755.34%68.57M	229.37%68.57M	0
Operating expense	-51.43%1.41M	-52.81%1.46M	-83.03%9.83M	-80.16%2.11M	-88.15%1.72M	-80.42%2.91M	-82.75%3.08M	-28.29%57.9M	113.69%10.65M	-75.82%14.52M
Selling and administrative expenses	-55.66%1.23M	-56.74%1.32M	-84.30%8.9M	-85.73%1.48M	-88.84%1.59M	-80.92%2.78M	-82.58%3.06M	-29.77%56.71M	114.34%10.34M	-75.62%14.25M
Depreciation amortization depletion	40.63%180K	392.59%133K	-22.72%922K	106.15%637K	-52.38%130K	-54.61%128K	-91.79%27K	--1.19M	--309K	--273K
-Depreciation and amortization	40.63%180K	392.59%133K	-22.72%922K	106.15%637K	-52.38%130K	-54.61%128K	-91.79%27K	--1.19M	--309K	--273K
Operating profit	52.31%-1.18M	57.18%-1.14M	-179.93%-8.52M	-102.78%-1.61M	87.79%-1.77M	83.36%-2.47M	85.08%-2.67M	113.40%10.66M	133.51%57.91M	63.63%-14.52M
Net non-operating interest income expense	88.89%-5K	0			-20K	-45K	-50K			0
Non-operating interest expense	-88.89%5K	--0	----	----	--20K	--45K	--50K	----	----	--0
Other net income (expense)	30.10%134K	-18.18%333K	108.14%781K	99.07%-88K	420.54%359K	743.75%103K	407K	-3,625.37%-9.59M	-118,362.50%-9.46M	-689.47%-112K
Special income (charges)	---1.26M	----	--0	----	----	--0	----	---9.47M	----	----
-Less：Restructuring and merger&acquisition	----	----	--0	----	----	----	----	--9.47M	----	----
-Less:Impairment of capital assets	--1.26M	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	1,254.37%1.4M	-18.18%333K	767.52%781K	-900.00%-88K	420.54%359K	743.75%103K	--407K	-143.01%-117K	37.50%11K	-689.47%-112K
Income before tax	56.50%-1.05M	64.98%-809K	-820.86%-7.74M	-103.27%-1.58M	90.20%-1.43M	83.77%-2.41M	87.08%-2.31M	101.35%1.07M	-3.38%48.45M	69.15%-14.63M
Income tax	0	0	-43K			0	0	0
Net income	54.85%-1.09M	79.63%-734K	-109.18%-10.28M	-101.14%-883K	88.34%-3.38M	-102.15%-2.41M	92.65%-3.6M	164.96%112M	280.87%77.7M	38.92%-28.97M
Net income continuous Operations	56.50%-1.05M	64.98%-809K	-816.85%-7.7M	-103.18%-1.54M	90.20%-1.43M	83.77%-2.41M	87.08%-2.31M	101.35%1.07M	-3.38%48.45M	69.15%-14.63M
Net income discontinuous operations	---40K	105.80%75K	-102.33%-2.58M	-97.75%658K	86.44%-1.94M	--0	95.85%-1.29M	219.13%110.92M	--29.25M	---14.33M
Minority interest income
Net income attributable to the parent company	54.85%-1.09M	79.63%-734K	-109.18%-10.28M	-101.14%-883K	88.34%-3.38M	-102.15%-2.41M	92.65%-3.6M	164.96%112M	280.87%77.7M	38.92%-28.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	54.85%-1.09M	79.63%-734K	-109.18%-10.28M	-101.14%-883K	88.34%-3.38M	-102.15%-2.41M	92.65%-3.6M	164.96%112M	280.87%77.7M	38.92%-28.97M
Basic earnings per share	62.50%-0.09	83.78%-0.06	-107.90%-0.98	-100.70%-0.06	89.78%-0.32	-101.87%-0.24	93.51%-0.37	157.29%12.41	271.00%8.55	44.31%-3.13
Diluted earnings per share	62.50%-0.09	83.78%-0.06	-108.19%-0.98	-100.74%-0.06	89.78%-0.32	-101.87%-0.24	93.51%-0.37	155.22%11.96	262.00%8.1	44.31%-3.13
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data